PASW
PASW
NASDAQ · Distributors

Ping An Biomedical Co Ltd

$1.39
-0.05 (-3.47%)
As of Nov 18, 10:15 PM ET ·
Financial Highlights (FY 2026)
Revenue
5.33M
Net Income
-2,003,615
Gross Margin
2.8%
Profit Margin
-37.6%
Rev Growth
-33.2%
D/E Ratio
0.22
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 2.8% 2.8% 33.1% 33.1%
Operating Margin -43.0% -38.7% 5.8% 5.9%
Profit Margin -37.6% -35.7% 4.3% 5.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.33M 7.98M 4.16M 3.93M
Gross Profit 148.3K 222.0K 1.37M 1.30M
Operating Income -2,296,050 -3,093,480 240.2K 230.4K
Net Income -2,003,615 -2,699,481 178.4K 196.3K
Gross Margin 2.8% 2.8% 33.1% 33.1%
Operating Margin -43.0% -38.7% 5.8% 5.9%
Profit Margin -37.6% -35.7% 4.3% 5.0%
Rev Growth -33.2% -33.2% -3.1% +16.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 399.6K 399.6K 2.56M 2.29M
Total Equity 1.81M 1.81M 2.63M 2.69M
D/E Ratio 0.22 0.22 0.97 0.85
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -2,295,413 -3,264,434 369.6K 361.5K
Free Cash Flow — — 206.6K 190.0K